Figure 1
From: Novel agents and strategies for overcoming EGFR TKIs resistance
New agents for overcoming AR. This figure shows the parallel and downstream signaling pathways of the EGFR. The gray boxes depict new agents available for treatment.
Figure 1 | Experimental Hematology & Oncology